Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9262146 [patent_doc_number] => 20130344075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 13/153692 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15675 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153692 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/153692
Polypeptide compounds for inhibiting angiogenesis and tumor growth Jun 5, 2011 Issued
Array ( [id] => 8842203 [patent_doc_number] => 20130137831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'OPTIMIZED DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/697437 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17336 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697437 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/697437
OPTIMIZED DRUG CONJUGATES May 24, 2011 Abandoned
Array ( [id] => 6089045 [patent_doc_number] => 20110217709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'DETECTION OF CHROMSOMAL REGION COPY NUMBER CHANGES TO DIAGNOSE MELANOMA' [patent_app_type] => utility [patent_app_number] => 13/110853 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14995 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217709.pdf [firstpage_image] =>[orig_patent_app_number] => 13110853 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/110853
DETECTION OF CHROMSOMAL REGION COPY NUMBER CHANGES TO DIAGNOSE MELANOMA May 17, 2011 Abandoned
Array ( [id] => 8042249 [patent_doc_number] => 20120070849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR RISK STRATIFICATION' [patent_app_type] => utility [patent_app_number] => 13/098902 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42117 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070849.pdf [firstpage_image] =>[orig_patent_app_number] => 13098902 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098902
METHODS AND COMPOSITIONS FOR RISK STRATIFICATION May 1, 2011 Abandoned
Array ( [id] => 8815298 [patent_doc_number] => 20130116343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Salivary Protein Markers for Detection of Breast Cancer' [patent_app_type] => utility [patent_app_number] => 13/642587 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25249 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642587 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/642587
Salivary Protein Markers for Detection of Breast Cancer Apr 20, 2011 Abandoned
Array ( [id] => 8940440 [patent_doc_number] => 20130190237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/639590 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 33562 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639590 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/639590
METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER Apr 5, 2011 Abandoned
Array ( [id] => 8346750 [patent_doc_number] => 20120207671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/501600 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31279 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501600 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/501600
COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS Apr 4, 2011 Abandoned
Array ( [id] => 5959479 [patent_doc_number] => 20110183866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER' [patent_app_type] => utility [patent_app_number] => 13/077380 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 100815 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183866.pdf [firstpage_image] =>[orig_patent_app_number] => 13077380 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/077380
COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER Mar 30, 2011 Abandoned
Array ( [id] => 8744861 [patent_doc_number] => 20130084578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'BREAST CANCER RELATED GENE ZNFN3A1' [patent_app_type] => utility [patent_app_number] => 13/076137 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15553 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13076137 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/076137
BREAST CANCER RELATED GENE ZNFN3A1 Mar 29, 2011 Abandoned
Array ( [id] => 8732685 [patent_doc_number] => 20130078255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'SERUM AND TISSUE BIOMARKERS OF HUMAN HCC' [patent_app_type] => utility [patent_app_number] => 13/637751 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13888 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637751 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/637751
SERUM AND TISSUE BIOMARKERS OF HUMAN HCC Mar 28, 2011 Abandoned
Array ( [id] => 8585697 [patent_doc_number] => 20130004519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'SMOCI, TENASCIN-C AND BRAIN CANCERS' [patent_app_type] => utility [patent_app_number] => 13/582268 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20790 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582268 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/582268
SMOCI, TENASCIN-C AND BRAIN CANCERS Mar 3, 2011 Abandoned
Array ( [id] => 9197654 [patent_doc_number] => 20130336969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'USE OF OLFACTOMEDIN-4 PROTEIN (OLFM4) IN COLORECTAL CANCER DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 14/002225 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12620 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002225 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/002225
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis Mar 1, 2011 Issued
Array ( [id] => 10091284 [patent_doc_number] => 09128101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Biomarkers for theranostics' [patent_app_type] => utility [patent_app_number] => 13/581795 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 195 [patent_figures_cnt] => 195 [patent_no_of_words] => 143911 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581795 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/581795
Biomarkers for theranostics Feb 28, 2011 Issued
Array ( [id] => 9388822 [patent_doc_number] => 08685416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Compositions and methods for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/581999 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 22098 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581999 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/581999
Compositions and methods for the treatment of cancer Feb 28, 2011 Issued
Array ( [id] => 6177252 [patent_doc_number] => 20110177971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR' [patent_app_type] => utility [patent_app_number] => 13/024845 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22415 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177971.pdf [firstpage_image] =>[orig_patent_app_number] => 13024845 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/024845
METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR Feb 9, 2011 Abandoned
Array ( [id] => 8442262 [patent_doc_number] => 20120258877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/024272 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29381 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13024272 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/024272
IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS Feb 8, 2011 Abandoned
Array ( [id] => 6063004 [patent_doc_number] => 20110200998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Prognosis and Therapy Predictive Markers and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/023331 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10856 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200998.pdf [firstpage_image] =>[orig_patent_app_number] => 13023331 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/023331
Prognosis and Therapy Predictive Markers and Methods of Use Feb 7, 2011 Abandoned
Array ( [id] => 8696854 [patent_doc_number] => 20130058863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => '4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen' [patent_app_type] => utility [patent_app_number] => 13/576877 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22010 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576877 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/576877
4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen Feb 3, 2011 Abandoned
Array ( [id] => 6142010 [patent_doc_number] => 20110129416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS' [patent_app_type] => utility [patent_app_number] => 13/012706 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28069 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129416.pdf [firstpage_image] =>[orig_patent_app_number] => 13012706 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/012706
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Jan 23, 2011 Issued
Array ( [id] => 8184230 [patent_doc_number] => 20120114670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS' [patent_app_type] => utility [patent_app_number] => 13/011901 [patent_app_country] => US [patent_app_date] => 2011-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 76259 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114670.pdf [firstpage_image] =>[orig_patent_app_number] => 13011901 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/011901
METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS Jan 22, 2011 Abandoned
Menu